Therefore, a better understanding of the mechanistic interplay between NRF2 and HIPK2 could help to elucidate not only the pro-survival/apoptotic outcome in cancer, especially in response to therapeutic agents, but also the induction of fibrosis. The gene discussed is HIPK2; the disease is cancer.